ABSTRACT
Objective: This study aimed to compare the efficacy and safety of ossein-hydroxyapatite complex (OHC) versus calcium carbonate (CC) for preventing bone loss during perimenopause in current clinical practice.Methods: The prospective, comparative, non-randomized, open-label study included 851 perimenopausal women with basal bone mineral density (BMD) T-score ≥-2 standard deviations (SDs). Participants received either OHC (712 mg calcium/day) or CC (1000 mg calcium/day) over 3 years. BMD was evaluated by dual-energy X-ray absorptiometry at the lumbar spine (L2-L4) at baseline and after 18 and 36 months of follow-up. Adverse drug reactions (ADRs) were also recorded.Results: In women receiving OHC, BMD at the L2-L4 site remained stable over the 3-year follow-up period (mean [SD] change 0.00 [0.11] g/cm2). BMD in the CC arm decreased -3.1% (mean [SD] - 0.03 [0.11] g/cm2). Between-group differences were statistically significant (p < 0.001) and favored OHC. ADRs were more frequent in the CC group (7.7% vs. 2.7% in the OHC group; p = 0.001), affecting primarily the gastrointestinal system.Conclusion: OHC showed greater efficacy and tolerability than CC for bone loss prevention in perimenopausal women in real-world practice. As the daily dose of calcium was higher in the CC group, the differences might be linked to the ossein compound in OHC.
Subject(s)
Calcium Carbonate/therapeutic use , Durapatite/therapeutic use , Osteoporosis, Postmenopausal/drug therapy , Absorptiometry, Photon , Bone Density , Calcium Carbonate/administration & dosage , Durapatite/administration & dosage , Female , Humans , Lumbar Vertebrae , Middle Aged , Osteoporosis, Postmenopausal/diagnostic imaging , Perimenopause , Prospective Studies , Spain , Treatment OutcomeABSTRACT
Tumours originating from the laryngeal skeleton are a rarity. We present a case report of an 82 year old male with chondroma in the larynx. 23 years before, the tumour was diagnosed when the patient was asymptomatic. 10 years later he was operated up on with conservative surgery when the tumour grew to a size that caused permanent dyspnoea and dysphonia. After regular examinations, 13 years later, there is no evidence of recurrence of the mass. Chondromas are rare. Surgical extirpation is the essential line of treatment for tumours of the cricoid cartilage.
